MaaT Pharma SA (EPA:MAAT)

MaaT Pharma Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	15.04	20.15	24.28	35.25	43.31	19.91
Short-Term Investments	-	-	-	0.06	-	-
Cash & Short-Term Investments	15.04	20.15	24.28	35.31	43.31	19.91
Cash Growth	-51.72%	-16.99%	-31.24%	-18.46%	117.47%	268.01%
Accounts Receivable	18.23	5.03	5.16	4.24	2.39	1.65
Other Receivables	1.27	1.12	1.04	0.78	0.98	0.59
Receivables	19.5	6.15	6.21	5.02	3.37	2.24
Inventory	0.09	0.06	0.19	0.05	0.03	-
Prepaid Expenses	0.85	1.07	1.13	1.58	0.43	0.04
Other Current Assets	0.1	0.21	0.19	0.16	0.13	0
Total Current Assets	35.57	27.64	31.99	42.12	47.27	22.19
Property, Plant & Equipment	7.91	8.6	9.17	0.97	1.11	1.1
Long-Term Investments	-	-	-	-	0.1	0.1
Other Intangible Assets	2.85	1.77	1.34	1.2	0.81	0.75
Other Long-Term Assets	2.2	0.2	0.2	0.3	-	-0
Total Assets	48.88	38.5	42.93	44.73	49.42	24.28
Accounts Payable	10.17	8.83	6.35	4.51	2.47	1.4
Accrued Expenses	2.5	1.99	1.29	1.24	0.69	0.49
Current Portion of Long-Term Debt	2.55	1.85	2.22	2.77	1.06	0.78
Current Portion of Leases	-	1.28	1.23	0.21	0.19	0.08
Current Income Taxes Payable	0.12	0.09	0.06	0.05	0.03	0.03
Other Current Liabilities	0.71	0.53	0.37	0.44	0.25	0.07
Total Current Liabilities	16.04	14.56	11.52	9.22	4.7	2.86
Long-Term Debt	6.34	8.11	5.75	7.94	3.98	4.72
Long-Term Leases	5.52	4.72	4.88	0.43	0.57	0.49
Other Long-Term Liabilities	12.49	0.6	0.15	0.23	0.19	0.19
Total Liabilities	40.58	28.17	22.47	17.92	9.56	8.34
Common Stock	1.61	1.4	1.16	0.99	0.99	0.66
Additional Paid-In Capital	20.38	35.48	37.38	38.32	46.46	19.91
Retained Earnings	-13.43	-26.3	-17.86	-12.37	-7.6	-4.63
Treasury Stock	-0.27	-0.23	-0.22	-0.14	-	-
Shareholders' Equity	8.3	10.34	20.47	26.81	39.86	15.94
Total Liabilities & Equity	48.88	38.5	42.93	44.73	49.42	24.28
Total Debt	14.41	15.96	14.08	11.36	5.81	6.08
Net Cash (Debt)	0.63	4.2	10.21	23.95	37.5	13.84
Net Cash Growth	-95.47%	-58.87%	-57.39%	-36.13%	171.00%	-
Net Cash Per Share	0.04	0.32	0.90	2.42	15.45	13.40
Filing Date Shares Outstanding	15.11	16.08	11.6	11.54	9.89	1.03
Total Common Shares Outstanding	15.11	13.95	11.59	9.94	9.88	1.03
Working Capital	19.53	13.08	20.47	32.91	42.57	19.33
Book Value Per Share	0.55	0.74	1.77	2.70	4.03	15.44
Tangible Book Value	5.44	8.57	19.12	25.61	39.05	15.19
Tangible Book Value Per Share	0.36	0.61	1.65	2.58	3.95	14.71
Machinery	1.41	1.35	1.24	0.99	0.73	0.65
Construction In Progress	0.62	0.56	0.52	0.07	-	0.12

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.